Amgen Inc.
STABILIZED RECEPTOR POLYPEPTIDES AND USES THEREOF

Last updated:

Abstract:

The present invention provides stabilized activin IIB receptor polypeptides and proteins capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing the stabilized polypeptides and proteins. Compositions and methods for treating muscle-wasting diseases and metabolic disorders are also provided.

Status:
Application
Type:

Utility

Filling date:

18 Apr 2019

Issue date:

26 Dec 2019